Invesco
EVH icon

Invesco’s Evolent Health EVH Stock Holding History

Invesco’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
443,924
+51,642
+13% +$164K ﹤0.01% 2855
2025
Q4 		$1.57M Buy
392,282
+91,370
+30% +$508K ﹤0.01% 2711
2025
Q3 		$2.55M Buy
300,912
+79,619
+36% +$773K ﹤0.01% 2523
2025
Q2 		$2.49M Buy
221,293
+52,800
+31% +$485K ﹤0.01% 2494
2025
Q1 		$1.6M Buy
168,493
+52,872
+46% +$534K ﹤0.01% 2632
2024
Q4 		$1.3M Sell
115,621
-1,177,724
-91% -$20.7M ﹤0.01% 2801
2024
Q3 		$36.6M Sell
1,293,345
-162,939
-11% -$4.2M 0.01% 1176
2024
Q2 		$27.8M Sell
1,456,284
-502,178
-26% -$12.8M 0.01% 1275
2024
Q1 		$64.2M Sell
1,958,462
-115,986
-6% -$3.7M 0.01% 940
2023
Q4 		$68.5M Buy
2,074,448
+142,271
+7% +$4.03M 0.02% 882
2023
Q3 		$52.6M Sell
1,932,177
-1,084,848
-36% -$30.2M 0.01% 933
2023
Q2 		$91.4M Sell
3,017,025
-325,561
-10% -$10.5M 0.02% 749
2023
Q1 		$108M Buy
3,342,586
+438,179
+15% +$13.9M 0.03% 682
2022
Q4 		$81.6M Buy
2,904,407
+260,307
+10% +$7.46M 0.02% 769
2022
Q3 		$95M Buy
2,644,100
+1,350,003
+104% +$47.6M 0.03% 683
2022
Q2 		$39.7M Buy
1,294,097
+644,960
+99% +$18.8M 0.01% 1023
2022
Q1 		$21M Buy
649,137
+560,438
+632% +$14.7M 0.01% 1482
2021
Q4 		$2.45M Sell
88,699
-255,155
-74% -$7.32M ﹤0.01% 2724
2021
Q3 		$10.7M Buy
343,854
+162,609
+90% +$3.9M ﹤0.01% 1969
2021
Q2 		$3.83M Sell
181,245
-257,875
-59% -$5.16M ﹤0.01% 2555
2021
Q1 		$8.87M Buy
439,120
+238,840
+119% +$4.54M ﹤0.01% 2031
2020
Q4 		$3.21M Buy
200,280
+28,668
+17% +$379K ﹤0.01% 2412
2020
Q3 		$2.13M Buy
171,612
+69,870
+69% +$822K ﹤0.01% 2460
2020
Q2 		$725K Sell
101,742
-11,051
-10% -$74K ﹤0.01% 2963
2020
Q1 		$613K Buy
112,793
+53,077
+89% +$474K ﹤0.01% 2966
2019
Q4 		$540K Sell
59,716
-3,825
-6% -$31.1K ﹤0.01% 3216
2019
Q3 		$457K Sell
63,541
-1,708
-3% -$12.3K ﹤0.01% 3287
2019
Q2 		$519K Sell
65,249
-362,425
-85% -$4.29M ﹤0.01% 3301
2019
Q1 		$5.38M Buy
427,674
+75,112
+21% +$1.19M ﹤0.01% 1964
2018
Q4 		$7.03M Buy
352,562
+17,615
+5% +$408K ﹤0.01% 1749
2018
Q3 		$9.51M Sell
334,947
-25,461
-7% -$607K ﹤0.01% 1736
2018
Q2 		$7.59M Sell
360,408
-29,421
-8% -$557K ﹤0.01% 1860
2018
Q1 		$5.55M Buy
389,829
+38,697
+11% +$554K ﹤0.01% 1888
2017
Q4 		$4.32M Sell
351,132
-1,947,044
-85% -$27.4M ﹤0.01% 2080
2017
Q3 		$40.9M Sell
2,298,176
-6,307
-0.3% -$130K 0.02% 868
2017
Q2 		$58.4M Buy
2,304,483
+38,749
+2% +$932K 0.02% 701
2017
Q1 		$50.5M Buy
2,265,734
+2,119,233
+1,447% +$40.7M 0.02% 779
2016
Q4 		$2.17M Sell
146,501
-76,013
-34% -$1.5M ﹤0.01% 2515
2016
Q3 		$5.48M Buy
+222,514
New +$5.2M ﹤0.01% 1903

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's EVH Position: Q1 2026 in Review

Invesco increased its Evolent Health (EVH) stake by 13% in Q1 2026, buying an estimated $164K and bringing the position to 443,924 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Invesco first reported a position in EVH in Q3 2016 and has held it in 39 quarters since. The position peaked at $108M in Q1 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Invesco held 443,924 shares of Evolent Health worth $1.01M as of Q1 2026.
  • Invesco bought 51,642 Evolent Health shares in Q1 2026, an estimated $164K.
  • Evolent Health made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2855 holding.
  • Invesco first reported a position in Evolent Health in Q3 2016 and has held it in 39 quarters since.
  • Invesco's Evolent Health position peaked at $108M in Q1 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.